PTC THERAPEUTICS, INC. (PTCT) › Cash & EquivalentsPTC THERAPEUTICS, INC. (PTCT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $28.67M2011: $28.43M2012: $2.73M2013: $15.41M2014: $49.75M2015: $58.02M2016: $58.32M2017: $111.79M2018: $169.50M2019: $288.03M2020: $208.81M2021: $189.72M2022: $279.83M2023: $594.00M2024: $779.71M2025: $984.65M$984.65M2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$984.65M+26.3%2024$779.71M+31.3%2023$594.00M+112.3%2022$279.83M+47.5%2021$189.72M-9.1%2020$208.81M-27.5%2019$288.03M+69.9%2018$169.50M+51.6%2017$111.79M+91.7%2016$58.32M+0.5%2015$58.02M+16.6%2014$49.75M+222.7%2013$15.41M+465.4%2012$2.73M-90.4%2011$28.43M-0.8%2010$28.67M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share